Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Schirosi L, Nannini N, Nicoli D, Cavazza A, Valli R, Buti S, Garagnani L, Sartori G, Calabrese F, Marchetti A, Buttitta F, Felicioni L, Migaldi M, Rea F, Di Chiara F, Mengoli MC, Rossi G.
Schirosi L, et al. Among authors: garagnani l.
Ann Oncol. 2012 Sep;23(9):2409-2414. doi: 10.1093/annonc/mdr626. Epub 2012 Feb 21.
Ann Oncol. 2012.
PMID: 22357254
Free article.